As financial savings and patient benefits, such as health insurance, are emerging as major issues both domestically and globally, biosimilars that have the same effect as the original and are cheaper are expanding their presence.

It is the expert's view that the effects are felt even when looking at overseas cases where active prescriptions are already being made. Samsung Bioepis held a satellite symposium at the 15th World Lupus Academic Conference, the 43rd Korean Society of Rheumatology Spring Conference, and the 17th LUPUS & KCR 2023 organized by the Korean Lupus Research Association and the Korean Society of Rheumatology, which were held at COEX on the 18th. The role of biosimilars was discussed. This